Discover how proteomic analysis of banana xylem sap reveals resistance mechanisms against Fusarium oxysporum TR4, the deadly banana fungus threatening global production.
Exploring groundbreaking patents and therapies targeting the p53 protein to revolutionize cancer treatment.
Exploring how PKM2 phosphorylates Matrin 3 to promote FOXC2-mediated tumorigenesis in cancer metabolism.
Discover how dihydroartemisinin (DHA), derived from ancient antimalarial plants, targets PDGFRα in aggressive ovarian cancer, offering new hope against this lethal disease.
Discover how a 13-gene signature predicts response to MDM2 inhibitors in p53 wild-type cancers, enabling personalized therapy approaches.
Discover how EWS-FLI1 orchestrates Ewing sarcoma plasticity through a post-translational modification cascade regulating FOXM1 stability.
Discover how bortezomib, a cancer drug, shows promise in treating Niemann-Pick Type C disease by rescuing misfolded NPC1 proteins and reducing cholesterol accumulation.
Explore the revolutionary frontier of cancer chemoprevention - a strategy that helps your cells stay cancer-free through natural compounds and repurposed drugs.
Discover how MetaDegron's multimodal AI predicts cellular protein degradation signals (degrons) with unprecedented accuracy, opening new frontiers in drug discovery.
Exploring how hyperactivating cancer pathways can be a novel synthetic lethality approach in oncology